Finance

Beta
Lists
532872:BOM
Sun Pharma Advanced Research Co Ltd
₹212.45
-0.21%
(-0.45) 1D
Jun 5, 3:54:53 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532872...
Open
₹214.85
High
₹222.00
Low
₹210.85
Mkt. cap
68.97B
Avg. vol.
477.63K
Volume
250.26K
P/E ratio
4.44
52-wk high
₹248.65
52-wk low
₹108.20
EPS
₹47.86
Shares outstanding
255.99M
No. of employees
316
Open
₹214.85
High
₹222.00
Low
₹210.85
Mkt. cap
68.97B
Avg. vol.
477.63K
Volume
250.26K
P/E ratio
4.44
52-wk high
₹248.65
52-wk low
₹108.20
EPS
₹47.86
Shares outstanding
255.99M
No. of employees
316
News stories
From sources across the web
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees316
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitesparc.life
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
96.40M
78.60M
84.50M
18.53B
Cost of goods sold
51.30M
61.00M
72.10M
51.60M
Cost of revenue
51.30M
61.00M
72.10M
51.60M
Research and development expenses
55.40M
80.10M
62.70M
28.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
413.90M
483.40M
424.60M
553.20M
Operating expense
592.70M
700.40M
604.50M
772.60M
Total operating expenses
644.00M
761.40M
676.60M
824.20M
Operating income
-547.60M
-682.80M
-592.10M
17.71B
Other non operating income
91.40M
100.00K
-
18.00M
EBT including unusual items
-518.10M
-757.90M
-803.50M
17.61B
EBT excluding unusual items
-518.10M
-757.90M
-679.90M
17.61B
Income tax expense
600.00K
600.00K
700.00K
-3.80M
Effective tax rate
-0.12%
-0.08%
-0.09%
-0.02%
Other operating expenses
96.60M
111.30M
91.50M
167.00M
Net income
-518.70M
-758.50M
-804.20M
17.61B
Net profit margin
-538.07%
-965.01%
-951.72%
95.04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-61.90M
-75.20M
-87.80M
-116.40M
Net interest expenses
-61.90M
-75.20M
-87.80M
-116.40M
Depreciation and amortization charges
26.80M
25.60M
25.70M
24.00M
EBITDA
-526.25M
-656.60M
-570.75M
17.73B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer